HIV evolution and progression of the infection to AIDS

Journal of Theoretical Biology

Volumn 307, Issue , 2012, Pages 149-159

  Huang, Gang ^a   Takeuchi, Yasuhiro ^b   Korobeinikov, Andrei ^c  

^a CHINA UNIVERSITY OF GEOSCIENCES   (China)

^b SHIZUOKA UNIVERSITY   (Japan)

^c UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

CD4 +T cells; Mathematical modeling; Specific CTL response; Viral evolution

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EVOLUTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNE SYSTEM; MUTATION; NUMERICAL MODEL; QUANTITATIVE ANALYSIS; THRESHOLD; VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; EVOLUTION; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE ACTIVATION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION CONTROL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPOIESIS; MATHEMATICAL MODEL; PRIORITY JOURNAL; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BIOLOGICAL EVOLUTION; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DISEASE PROGRESSION; HIV; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, BIOLOGICAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84861953719     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.05.013     Document Type: Article

References (68)

1. +T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 2003, 84(7):1649-1661.
2. Allen T.M., et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000, 407:386-390.
3. Altes H.K., Wodarz D., Jansen V.A.A. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination. J. Theor. Biol. 2002, 214:633-646.
4. Asjo B., Albert J., Karlsson A., Morfeldtmanson L., Biberfeld G., Lidman K., Fenyo E.M. Replication capacity of human immunodeficiency virus (HIV) from patients with varying severity of HIV infection. Lancet 1986, 2(8508):660-662.
5. Barouch D.H., et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002, 415:335-339.
6. Bittner B., Bonhoeffer S., Howak M.A. Virus load and antigenic diversity. Soc. Math. Biol. 1997, 59:881-896.
7. Cohen O.J., Fauci A.S. Transmission of multidrug-resistant human immunodeficiency virus E-the wake-up call. N. Engl. J. Med. 1998, 339:341-343.
8. de Boer R.J., Boerlijst M.C. Diversity and virulence thresholds in AIDS. Proc. Natl. Acad. Sci. USA 1994, 94:544-548.
9. de Baer R.J., Perelson A.S. Target cell limited and immune control models of HIV infection: a comparison. J. Theor. Biol. 1998, 190:201-214.
10. Dempsey, C., Korobeinikov, A. HIV evolution within a host. R. Soc. Interface, submitted for publication.
11. Funk G.A., Jansen V.A.A., Bonhoeffer S., Killingback T. Spatial models of virus-immune dynamics. J. Theor. Biol. 2005, 233:221-236.
12. Galvani A.P. The role of mutation accumulation in HIV progression. Proc. R. Soc. Lond. B 2005, 272:1851-1858.
13. Gamberg J., Grant M. Cytotoxic T lymphocytes in human immunodeficiency virus type-1 infection. Clin. Appl. Immunol. Rev. 2000, 1:17-36.
14. Gorban A.N. Selection Theorem for Systems With Inheritance. Math. Model. Nat. Phenom. 2007, 2:1-45.
15. Holmes E.C., Zhang L.Q., Simmonds P., Ludlam C.A., Brown A.J. Convergent and divergent sequence evolution in the surface envelope glycoprotein of HIV-1 within a single infected patients. Proc. Natl. Acad. Sci. USA 1992, 89:4835-4839.
16. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
17. Iwami S., Miura T., Nakaoka S., Takeuchi Y. Immune impairment in HIV infection: existence of risky and immunodeficiency thresholds. J. Theor. Biol. 2009, 260:490-501.
18. Iwami S., Nakaoka S., Takeuchi Y., Miura Y., Miura T. Immune impairment thresholds in HIV infection. Immunol. Lett. 2009, 123:149-154.
19. Iwasa Y., Michor F., Nowak M.A. Some basic properties of immune selection. J. Theor. Biol. 2004, 229:179-188.
20. Iwasa Y., Michor F., Nowak M.A. Virus evolution within patients increases pathogenicity. J. Theor. Biol. 2005, 232:17-26.
21. Janewa, C., Travers, P., Walport, M., Shlomchik, M.J., 2004. Immunobiology: The Immune System in Health and Disease. Garland Pub.
22. Jost S., et al. A patient with HIV-1 superinfection. N. Engl. J. Med. 2002, 347:731-736.
23. Jung A., et al. Recombination: multiply infected spleen cells in HIV patients. Nature 2002, 418:144.
24. Koelsch K.K., et al. Clade B HIV-1 superinfection with wildtype virus after primary infection with drug-resistant clade B virus. AIDS 2003, 17:F11-F16.
25. Krakauer D.C., Nowak M. T-cell induced pathogenesis in HIV: bystander effects and latent infection. Proc. R. Soc. Lond. B 1999, 266:1069-1075.
26. Levin B.R., Bull J.J., Stewart F.M. Epidemiology, evolution, and future of the HIV/AIDS pandemic. Emerg. Infect. Dis. 2001, 7:505-511.
27. Li M.Y., Shu H. Multiple stable periodic oscillations in a mathematical model of CTL response to HTLV-1 infection. Bull. Math. Biol. 2011, 73:1774-1793. doi:10.1007/s11538-010-9591-7.
28. +T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability. J. Exp. Med. 2000, 191:2159-2170.
29. Markham R.B., et al. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc. Natl. Acad. Sci. USA 1998, 95:12568-12573.
30. McMichael A.J., Phillips R.E. Escape of human immunodeficiency virus from immune control. Ann. Rev. Immunol. 1997, 15:271-296.
31. Mohri H., et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 2001, 194:1277-1287. http://www.jem.org/cgi/content/full/194/9/1277.
32. Moskophidis D., Battegay M., van den Broek M., Laine E., Hoffmann-Rohrer U., Zinkernagel R.M. Role of virus and host variables in virus persistence or immunopathological disease caused by non-cytolytic virus. J. Gen. Virol. 1995, 76:381-391.
33. Neher R.A., Leitner T. Recombination rate and selection strength in HIV intrapatient evolution. PLoS Computat. Biol. 2001, 6:e1000660.
34. Nelson G.W., Perelson A.S. A mechanism of immune escape by slow replicating HIV strains. AIDS 1992, 5:82-93.
35. +T helper cells and the role they play in viral control. J. Mol. Med. 2002, 80:397-405.
36. Nowak, M.A., 2006. HIV infection. In: Evolutionary Dynamics: Exploring the Equations of Life. The Belknap Press of Harvard University Press, pp. 168-188.
37. Nowak M.A., Anderson R.M., Mclean A.R., Wolfs T.F., Goudsmit J., May R.M. Antigenic diversity thresholds and the development of AIDS. Science 1991, 254:963-969.
38. Nowak M.A., Bangham C.R.M. Population dynamics of immune responses to persistent virus. Science 1996, 272:74-79.
39. Nowak M.A., May R.M., Sigmund K. Immune responses against multiple epitopes. J. Theor. Biol. 1995, 175:325-353.
40. Nowak M.A., May R.M. Virus Dynamics 2000, Oxford University Press.
41. Pantaleo G., Graziosi C., Fauci A.S. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 1993, 328:327-335.
42. Pantaleo G., Fauci A.S. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 1995, 13:487-512. doi:10.1146/annurev.iy.13.040195.002415.
43. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
44. Perelson A.S., Ribeiro R.M. Estimating drug efficacy and viral dynamic parameters: HIV and HCV. Statist. Med. 2008, 27:4647-4657.
45. Piatak M., Saag M.S., Yang L.C., Clark S.J., Kappes J.C., Luk K.C., Hahn B.H., Shaw G.M., Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259(5102):1749-1754. doi:10.1126/science.8096089.PMID8096089.
46. Preston B.D., Poiesz B.J., Loeb L.A. Fidelity of HIV-1 reverse transcriptase. Science 1988, 242:1169-1171.
47. Rambaut A., Posada D., Crandall K.A., Holmes E.C. The causes and consequences of HIV evolution. Nat. Rev. 2004, 5:52-61.
48. Regoes R.R., Wodarz D., Nowak M.A. Virus dynamics: the effect of target cell limitation and immune responses on virus evolution. J. Theor. Biol. 1998, 191:451-462.
49. Rinaldo C.R., Huang X.L., Fan Z., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M., Gupta P. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long term nonprogressors. J. Virol. 1995, 69:5838-5842.
50. Robertson D.L., Hahn B.H., Sharp P.M. Recombination in AIDS viruses. J. Mol. Evol. 1995, 40:249-259. doi:10.1007/BF00163230.
51. +T cells depleted?. Rroc. Natl. Acad. Sci. USA 2002, 99:15572-15577. doi:10.1073/pnas.242358099.
52. Stafford M.A., Corey L., Cao Y., Daar E.S., Ho D.D., Perlson A.S. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 2000, 203:285-301.
53. Shankarappa R., et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 1999, 73:10489-10502.
54. Tersmette M., Gruters R.A., Dewolf F., DeGoede R.E.Y., Lange J.M.A., Schellekens P.T.A., et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Viol. 1989, 63:2218-2225.
55. Tunetsugu-Yokota Y. How does HIV infection destroy the host immune system. J. AIDS Res. 2005, 7:171-179.
56. Vargas-De-León, C., Korobeinikov, A., 2011. Global stability of a population dynamics model with inhibition and negative feedback. Mathematical Medicine and Biology. http://doi:10.1093/imammb/dqr027.
57. Walker B.D., Korber B.T. Immune control of HIV: the obstacles of HLA and viral diversity. Nat. Immunol. 2001, 2:473-475.
58. Wodarz D. Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses. J. Gen. Viol. 2003, 84:1743-1750.
59. Wodarz D. Killer Cell Dynamics: Mathematical and Computational Approaches to Immunology 2007, Springer Verlag, New York.
60. Wodarz D., Christensen J.P., Thomsen A.R. The importance of lytic and nonlytic immune responses in viral infections. TRENDS Immunol. 2002, 23:194-200.
61. Wodarz D., Jansen V.A.A. The role of T cell help for anti-viral CTL responses. J. Theor. Biol. 2001, 211:419-432.
62. Wodarz D., Klenerman P., Nowak M.A. Dynamics of cytotoxic T-lymphocyte exhaustion. Proc. R. Soc. Lond. B 1998, 265:191-203.
63. Wodarz D., Nowak M.A. Specific therapy regimes could lead to long-term immunological control of HIV. Proc. Natl. Acad. Sci. USA 1999, 96:14464-14469.
64. Wodarz D., et al. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc. R. Soc. Lond. B 2001, 268:1215-1221.
65. Wodarz D., Thomsen A.R. Does programmed CTL proliferation optimize virus control. TRENDS Immunol. 2005, 26:305-310.
66. Wolinksy S.M., et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996, 272:537-542.
67. Yin E.Z., Frush D.P., Donnelly L.F., Buckley R.H. Primary immunodeficiency disorders in pediatric patients: clinical features and imaging findings. AJR 2001, 176:1541-1551.
68. Zhuang J., et al. Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J. Virol. 2002, 76:11273-11282.